Newsletters

Greetings, MAPS members and friends! The longest day of winter has passed, and maybe so has the decades-long era of resistance to psychedelic research. On December 17, the FDA approved Dr. John Halpern’s …

Greetings, MAPS members and friends! Election results got ya down? Starting to get the holiday blues? Looking for something to brighten your November? Read on! We’ve got so much good news I’m …

Greetings, MAPS members and friends! It continues to be a busy and productive summer as we move forward on projects in progress and on those still in the “visionary” stage… 1. MAPS launches …

Greetings MAPS members and friends, We’ve just returned from MAPS fantastic “Body Electric” fundraiser event, which brought over 200 people to Manhattan to eat, converse, and dance through …

Greetings, MAPS members and friends! These have been very busy and productive times for the MAPS staff, as we’ve been traveling to conferences and out of the office for several weeks. In early June, …

Greetings, MAPS members and friends! We’re proud to be able to include a historic and exciting report in this month’s email newsletter. 1. MAPS’ MDMA/PTSD study fully approved!! And in …

Greetings, MAPS members and friends! We’re proud to be able to include a historic and exciting report in this month’s email newsletter. 1. MAPS’ MDMA/PTSD study fully approved!! And in …

Hello, MAPS members and friends! In today’s news from MAPS: 1. FDA replies to DEA regarding Dr. Michael Mithoefer’s Schedule I license for MDMA/PTSD study; DEA should respond soon 2. Dr. Mithoefer …

Greetings, MAPS members! In this issue, we have a number of research news items as well as some notes from the MAPS staff: About research: 1. Great 12/2/03 NY Times article on Ricaurte’s MDMA research …

Happy Autumn, MAPS members! It’s been a while since the last email update, and we’ve been quite busy — as you’ll read here. In this issue: 1. DEA agents inspect Dr. Mithoefer’s …

MAPS News 9/24/03: A historic day Hello, MAPS members- We have wonderful news! Yesterday (Tuesday, September 23, 2003), the Institutional Review Board reviewing Dr. Mithoefer’s MDMA/PTSD protocol …

Greetings, MAPS members! This is the third edition of the MAPS news email update. We’re happy to report several items of progress in both research projects and in our efforts at outreach and education. …